Stocktoria
Design Therapeutics, Inc. DSGN
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-03-26
Design Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| Point72 Asset Management, L.P. | 2,722,754 | $29.0M | 4.51% |
| BlackRock Finance, Inc. | 2,304,948 | $7.7M | 3.82% |
| D. E. Shaw & Co., Inc. | 470,270 | $5.0M | 0.78% |
| RENAISSANCE TECHNOLOGIES LLC | 408,200 | $4.3M | 0.68% |
| CITADEL ADVISORS LLC | 231,513 | $2.5M | 0.38% |
| MILLENNIUM MANAGEMENT LLC | 108,928 | $1.2M | 0.18% |
| AQR CAPITAL MANAGEMENT LLC | 25,957 | $276,184 | 0.04% |
| TWO SIGMA INVESTMENTS, LP | 16,300 | $173,432 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.